- Home
- HROW vs EVH Comparison
HROW vs EVH Comparison
Compare HROW & EVH Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- HROW
- EVH
- Stock Information
- Founded
- HROW 1998
- EVH 2011
- Country
- HROW United States
- EVH United States
- Employees
- HROW N/A
- EVH N/A
- Industry
- HROW Biotechnology: Pharmaceutical Preparations
- EVH Other Consumer Services
- Sector
- HROW Health Care
- EVH Consumer Discretionary
- Exchange
- HROW Nasdaq
- EVH Nasdaq
- Market Cap
- HROW 1.0B
- EVH 1.1B
- IPO Year
- HROW N/A
- EVH 2015
- Fundamental
- Price
- HROW $24.98
- EVH $9.70
- Analyst Decision
- HROW Strong Buy
- EVH Strong Buy
- Analyst Count
- HROW 5
- EVH 14
- Target Price
- HROW $58.40
- EVH $16.71
- AVG Volume (30 Days)
- HROW 691.9K
- EVH 2.3M
- Earning Date
- HROW 05-12-2025
- EVH 05-08-2025
- Dividend Yield
- HROW N/A
- EVH N/A
- EPS Growth
- HROW N/A
- EVH N/A
- EPS
- HROW N/A
- EVH N/A
- Revenue
- HROW $199,614,000.00
- EVH $2,554,741,000.00
- Revenue This Year
- HROW $45.63
- EVH N/A
- Revenue Next Year
- HROW $38.04
- EVH $16.02
- P/E Ratio
- HROW N/A
- EVH N/A
- Revenue Growth
- HROW 53.32
- EVH 30.09
- 52 Week Low
- HROW $9.86
- EVH $8.35
- 52 Week High
- HROW $59.23
- EVH $33.63
- Technical
- Relative Strength Index (RSI)
- HROW 41.63
- EVH 50.48
- Support Level
- HROW $25.17
- EVH $9.29
- Resistance Level
- HROW $30.73
- EVH $9.70
- Average True Range (ATR)
- HROW 2.18
- EVH 0.42
- MACD
- HROW 0.20
- EVH 0.03
- Stochastic Oscillator
- HROW 31.23
- EVH 48.33
About HROW Harrow Inc.
Harrow Inc is an eyecare pharmaceutical company engaged in the discovery, development, and commercialization of ophthalmic pharmaceutical products for the U.S. market. The company helps U.S. eyecare professionals preserve the gift of sight by making its comprehensive portfolio of prescription and non-prescription pharmaceutical products accessible and affordable to millions of Americans.
About EVH Evolent Health Inc
Evolent Health Inc is engaged in healthcare delivery and payment. The company supports health systems and physician organizations in their migration toward value-based care and population health management. It provides specialty care management services in oncology, cardiology, musculoskeletal markets and holistic total cost of care management along with an integrated platform for health plan administration and value-based business infrastructure under one go to market package. The primary solutions provided by the company include specialty care management services, total cost of care management, and administrative services.